Overactive Bladder Treatment Market Professional Survey Report 2018

0
13

This report studies the global Overactive Bladder Treatment market status and forecast, categorizes the global Overactive Bladder Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.

Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.

 

The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.

 

The global Overactive Bladder Treatment market is valued at 4710 million US$ in 2017 and will reach 7230 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2018-2025.

The major manufacturers covered in this report
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anticholinergics
Mirabegron
Botox

By Application, the market can be split into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder

The study objectives of this report are:
To analyze and study the global Overactive Bladder Treatment capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Overactive Bladder Treatment manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Overactive Bladder Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Overactive Bladder Treatment Manufacturers
Overactive Bladder Treatment Distributors/Traders/Wholesalers
Overactive Bladder Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With t

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here